Lysy B B - OmicsDI

Show results for

Unknown (20)
Proteomics (5)
Transcriptomics (1)
Metabolomics (1)

Organisms

Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (2)
Homo sapiens (2)
Salmonella enterica subsp. enterica serovar Enteritidis (1)
Campylobacter jejuni (1)

Repository

biostudies-arrayexpress (5)
MetaboLights (1)
pride (1)

Tissue

Blood plasma (1)

Disease

Type 1 diabetes mellitus (1)

Technology Type

Mass spectrometry (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Mass Spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)

Publication Date

2013 (4)
2011 (1)
2022 (1)
2024 (1)

CHEBI ID

CHEBI:100246 (1)
CHEBI:10025 (1)
CHEBI:10136 (1)
CHEBI:104011 (1)
CHEBI:10724 (1)
CHEBI:111517 (1)
CHEBI:1157 (1)
CHEBI:116314 (1)
CHEBI:132722 (1)
CHEBI:132983 (1)
CHEBI:134014 (1)
CHEBI:134015 (1)
CHEBI:134190 (1)
CHEBI:134480 (1)
CHEBI:135821 (1)
CHEBI:1372 (1)
CHEBI:137202 (1)
CHEBI:137225 (1)
CHEBI:137248 (1)
CHEBI:137290 (1)
CHEBI:137728 (1)
CHEBI:138364 (1)
CHEBI:138529 (1)
CHEBI:138667 (1)
CHEBI:138775 (1)
CHEBI:138776 (1)
CHEBI:138783 (1)
CHEBI:138784 (1)
CHEBI:138788 (1)
CHEBI:139123 (1)

Metabolite Name

(+)-2,3-Dihydro-3-methyl-1H-pyrrole (1)
(-)-Dioxibrassinin (1)
(-)-Epigallocatechin 3-cinnamate (1)
(-)-erythro-Anethole glycol 2-glucoside (1)
(10Z,14E,16E)-10,14,16-Octadecatrien-12-ynoic acid (1)
(1beta,2alpha,3alpha)-1,2,3,24-Tetrahydroxy-12-oleanen-28-oic acid (1)
(2'E,4'Z,7'Z,8E)-Colnelenic acid (1)
(2E)-Decenoyl-ACP (1)
(2R)-2-Hydroxy-2-methylbutanenitrile (1)
(2R,2'S)-Isobuteine (1)
(2R,3S)-Piscidic acid (1)
(2S,2''S,3S,3''R,4S)-3,4',5,7-Tetrahydroxyflavan(2->7,4->8)-3,4',5,7-tetrahydroxyflavan (1)
(2S,4S)-Pinnatanine (1)
(2alpha,3alpha,5alpha,22R,23R)-2,3,22,23-Tetrahydroxy-25-methylergost-24(28)en-6-one (1)
(3Z,6Z)-3,6-Nonadienal (1)
(3beta,22E,24R)-Ergosta-4,6,8(14),22-tetraen-3-ol (1)
(3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol (1)
(3xi,6xi)-Cyclo(alanylvalyl) (1)
(4-Hydroxybenzoyl)choline (1)
(7'S,8'S)-4,7'-Epoxy-3,8'-bilign-7-ene-3',5-dimethoxy-4',9,9'-triol 4'-glucoside (1)
(7R*,8R*)-3-Methoxy-3',4,7,9,9'-pentahydroxy-8,4'-oxyneolignan 4-xyloside (1)
(8R,8'R)-Secoisolariciresinol 9-glucoside (1)
(9R,10S,12Z)-9,10-Dihydroxy-8-oxo-12-octadecenoic acid (1)
(9S,10E,12Z,15Z)-9-Hydroxy-10,12,15-octadecatrienoic acid (1)
(9Z,11R,12S,13S,15Z)-12,13-Epoxy-11-hydroxy-9,15-octadecadienoic acid (1)
(E)-1-Propenyl 1-(propylthio)propyl disulfide (1)
(E)-Squamosamide (1)
(R)-2-Hydroxysterculic acid (1)
(R)-mandelic Acid (1)
(Z)-4-(1-Propenyl)phenol (1)

Study type

Proteomic profiling by array (4)
Transcription profiling by array (1)

Release Date

2013 (5)
2019 (5)
2022 (4)
2023 (2)
2015 (2)
2011 (1)
2025 (1)
2024 (1)
2021 (1)
2020 (1)
2016 (1)
2014 (1)

Lab affiliation

Pôle PEDI, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.

Not available

S-EPMC10688654 | biostudies-literature

Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice.

Not available

S-EPMC6701376 | biostudies-literature

Expression data by BRD7552 treatment in PANC-1 cells

Three master regulatory transcription factors Pdx1, MafA and Ngn3 have the ability to transdifferentiate pancreatic acinar cells to insulin-producing beta cells in mice. BRD7552 was identified as a small-molecule inducer that can upregulate the expression of Pdx1 in PANC-1 cells by high-throughput q...

ORGANISM(S): Homo sapiens

2013-03-10 | E-GEOD-44946 | biostudies-arrayexpress

Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency.

Not available

S-EPMC6360643 | biostudies-literature

Development of a Prediction Model for Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes: The Epi-GLUREDIA Study

Not available

S-EPMC12389539 | biostudies-literature

Plasma proteomics in children with new-onset type 1 diabetes: a strong tool to identify partial remission biomarkers

Partial remission (PR) occurs in only half of patients with new-onset type 1 diabetes (T1D) and correspond to a transient period characterized by low daily insulin needs, low glycemic fluctuations and increased endogenous insulin secretion. While identification of newly-onset T1D patients with signi...

ORGANISM(S): Homo sapiens (Human)

2024-04-05 | PXD049795 | Pride